Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
24.81
+1.01 (4.24%)
Oct 26, 2026, 12:30 PM EDT - Market open
Schrödinger Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 259.04 | 255.87 | 207.54 | 216.67 | 180.96 | 137.93 |
Revenue Growth | 8.88% | 23.29% | -4.21% | 19.73% | 31.19% | 27.60% |
Gross Profit Gross Profit Growth | 147.31 | 142.61 | 132.08 | 140.69 | 101.02 | 65.62 |
Operating Income Operating Income Growth | -153.45 | -166.9 | -209.3 | -177.45 | -146.82 | -111.44 |
Net Income Net Income Growth | -54.34 | -103.27 | -187.12 | 40.72 | -149.19 | -100.39 |
Earnings Per Share EPS Growth | -0.74 | -1.41 | -2.57 | 0.54 | -2.10 | -1.42 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Software Software Growth | 181.17 | 199.5 | 180.37 | 159.12 | 135.58 | 113.24 |
Drug Discovery Drug Discovery Growth | 77.87 | 56.37 | 27.17 | 57.54 | 45.38 | 24.7 |
Total Total Growth | 259.04 | 255.87 | 207.54 | 216.67 | 180.96 | 137.93 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 413.74 | 395.46 | 352.12 | 463 | 451.09 | 576.48 |
Total Debt Total Debt Growth | 108 | 109.31 | 117.83 | 127.88 | 116.49 | 79.87 |
Net Cash (Debt) Net Cash Growth | 305.74 | 286.15 | 234.3 | 335.12 | 334.6 | 496.61 |
Net Cash Growth | -8.94% | 22.13% | -30.09% | 0.16% | -32.62% | -21.29% |
Net Cash Per Share Net Cash Per Share Growth | 4.13 | 3.90 | 3.22 | 4.47 | 4.70 | 7.03 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -126.87 | 13.9 | -157.37 | -136.73 | -119.68 | -70.67 |
Capital Expenditures CapEx Growth | -3.4 | -1.44 | -7.31 | -13.4 | -8.01 | -7.17 |
Free Cash Flow Free Cash Flow Growth | -130.27 | 12.46 | -164.68 | -150.14 | -127.7 | -77.84 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 56.87% | 55.74% | 63.64% | 64.94% | 55.83% | 47.58% |
Operating Margin | -59.24% | -65.23% | -100.85% | -81.90% | -81.14% | -80.80% |
Pretax Margin | -20.05% | -39.99% | -89.48% | 19.81% | -82.41% | -73.09% |
Profit Margin | -20.98% | -40.36% | -90.16% | 18.79% | -82.44% | -72.78% |
FCF Margin | -50.29% | 4.87% | -79.35% | -69.29% | -70.57% | -56.43% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 63.33 | - | - |
P/FCF Ratio | - | 105.73 | - | - | - | - |
PS Ratio | 6.95 | 5.15 | 6.77 | 11.90 | 7.36 | 17.90 |